Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Capillary (finger‑prick) lactate to predict severity after major multi‑injury

Official title: Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma in Pre-hospital Care

Run by Centre Hospitalier Universitaire de Nice · NCT06969404 · Data updated 2026-11-12

This project will test whether a quick capillary (finger‑prick) lactate test at the injury scene can help predict which adults with potentially serious multi‑injury will have poor outcomes.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment550 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations3 sites (Antibes and 2 other locations)
StatusRecruiting
StartedFebruary 7, 2026
Main results expectedJune 15, 2027
Study endsDecember 15, 2027
Registry record updatedMarch 30, 2026
Trial IDNCT06969404 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with potentially serious pre‑hospital trauma (road accident or fall >2 m) attended by the SMUR 06 team and transferred to an emergency facility in the Alpes‑Maritimes are the ideal candidates.

Probably not a fit

Patients with isolated peripheral limb injuries, those under legal protection (guardianship/curatorship), patients in cardiorespiratory arrest on SMUR arrival, and minors are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Pre-hospital emergency teams will take a finger‑prick (capillary) blood sample from adults with potentially serious polytrauma and measure lactate levels on scene. Those capillary lactate values will be compared with clinical outcomes after transfer to participating emergency hospitals in the Alpes‑Maritimes to see if they predict poor outcomes similarly to venous lactate. Eligible cases include road traffic collisions or falls from over 2 metres requiring SMUR dispatch and medical transfer; pregnant patients may be included and consent can be obtained after stabilization. The study aims to determine whether a rapid, low‑risk point‑of‑care test can be incorporated into pre‑hospital triage protocols.

Why it matters

Potential benefit: If successful, a rapid capillary lactate test could help emergency teams quickly identify high‑risk trauma patients and improve triage and transport decisions.

How similar studies have gone: Venous lactate has been shown to predict poor outcomes in severe trauma, but using capillary lactate in the pre‑hospital setting is novel and not established in the published literature.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient over 18 years of age
* Presenting a potentially serious pre-hospital trauma defined by:

  o A road accident or a fall of more than 2 metres
* Requiring the dispatch of a SMUR 06 team (mobile emergency and resuscitation service)
* And transferred to an emergency facility in the Alpes Maritimes with medical assistance.
* Consent signed (by the patient or a relative) after the event if it is not possible to sign immediately.
* Pregnant women may also take part in the study without any risk to themselves or their child.

Exclusion Criteria:

* Patients with isolated peripheral limb trauma (wrist, elbow, knee, ankle, shoulder)
* Patients under legal protection (guardianship, curatorship)
* Patients in cardiorespiratory arrest when taken into care by the SMUR (emergency medical services)

Where it's running

  • Nice University Hospital
    Nice, France
    Recruiting
  • Antibes Hospital
    Antibes, France
    Not yet recruiting
  • Cannes hospital
    Cannes, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.